BIOMAT Database Logo BIOMAT Database Logo

Treatment of benign essential hypertension. 1966

W I Cranston

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

W I Cranston
THE TREATMENT OF BENIGN ESSENTIAL HYPERTENSION.
June 1964, The Journal of the Kentucky Medical Association,
W I Cranston
[Chlorothiazide in the treatment of benign essential hypertension].
June 1961, Prensa medica argentina,
W I Cranston
Benign inestigation of essential hypertension.
September 1969, Japanese heart journal,
W I Cranston
Benign investigation of essential hypertension.
January 1967, New Istanbul contribution to clinical science,
W I Cranston
Experiences with Chlortalidone treatment in benign essential hypertension cases.
January 1984, Therapia Hungarica (English edition),
W I Cranston
Treatment of benign essential hypertension: comparison of furosemide and hydrochlorothiazide.
August 1975, European journal of clinical pharmacology,
W I Cranston
[Prolonged treatment of benign essential hypertension with reserpine and placebo].
July 1959, La Semana medica,
W I Cranston
Treatment of benign essential hypertension with frusemide in different doses.
January 1980, Pharmatherapeutica,
W I Cranston
Longevity in benign essential hypertension.
August 1952, Journal of the American Medical Association,
W I Cranston
Management of benign essential arterial hypertension.
December 1972, American heart journal,
Copied contents to your clipboard!